Literature DB >> 19009590

Polymeric drug delivery of platinum-based anticancer agents.

Katherine J Haxton1, Helen M Burt.   

Abstract

Platinum-based anticancer agents such as cisplatin and carboplatin are in widespread clinical use but associated with many side effects. Improving the delivery of cytotoxic platinum compounds may lead to reduced side effects and achieve greater efficacy at lower doses. Polymer-based therapeutics have been investigated as potential drug delivery vehicles for platinum-based drugs. Against a background of the chemistry and pharmacology of cytotoxic platinum compounds, this review discusses the formation and properties of platinum-polymer complexes, dendrimers, micelles, and microparticulates.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19009590     DOI： 10.1002/jps.21611

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


  22 in total

1.  Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy.

Authors:  Abhimanyu Paraskar; Shivani Soni; Bhaskar Roy; Anne-Laure Papa; Shiladitya Sengupta
Journal:  Nanotechnology       Date:  2012-02-24       Impact factor: 3.874

Review 2.  Nanocarriers for delivery of platinum anticancer drugs.

Authors:  Hardeep S Oberoi; Natalia V Nukolova; Alexander V Kabanov; Tatiana K Bronich
Journal:  Adv Drug Deliv Rev       Date:  2013-10-08       Impact factor: 15.470

3.  Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Authors:  Poulomi Sengupta; Sudipta Basu; Shivani Soni; Ambarish Pandey; Bhaskar Roy; Michael S Oh; Kenneth T Chin; Abhimanyu S Paraskar; Sasmit Sarangi; Yamicia Connor; Venkata S Sabbisetti; Jawahar Kopparam; Ashish Kulkarni; Katherine Muto; Chitra Amarasiriwardena; Innocent Jayawardene; Nicola Lupoli; Daniela M Dinulescu; Joseph V Bonventre; Raghunath A Mashelkar; Shiladitya Sengupta
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

4.  Rationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacy.

Authors:  Abhimanyu Paraskar; Shivani Soni; Sudipta Basu; Chitra J Amarasiriwardena; Nicola Lupoli; Shyam Srivats; Rituparna Sinha Roy; Shiladitya Sengupta
Journal:  Nanotechnology       Date:  2011-05-17       Impact factor: 3.874

Review 5.  Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery.

Authors:  Jeannine M Coburn; David L Kaplan
Journal:  Bioconjug Chem       Date:  2015-03-02       Impact factor: 4.774

Review 6.  Nanoscale metal-organic frameworks for biomedical imaging and drug delivery.

Authors:  Joseph Della Rocca; Demin Liu; Wenbin Lin
Journal:  Acc Chem Res       Date:  2011-06-07       Impact factor: 22.384

7.  Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.

Authors:  Abhimanyu S Paraskar; Shivani Soni; Kenneth T Chin; Padmaparna Chaudhuri; Katherine W Muto; Julia Berkowitz; Michael W Handlogten; Nathan J Alves; Basar Bilgicer; Daniela M Dinulescu; Raghunath A Mashelkar; Shiladitya Sengupta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-23       Impact factor: 11.205

Review 8.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

9.  Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads.

Authors:  Shanta Dhar; Weston L Daniel; David A Giljohann; Chad A Mirkin; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

10.  Cyclodextrin polymers as nanocarriers for sorafenib.

Authors:  Valentina Giglio; Maurizio Viale; Vittorio Bertone; Irena Maric; Rita Vaccarone; Graziella Vecchio
Journal:  Invest New Drugs       Date:  2017-11-08       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.